초록 ▼

By providing a mixture of surfactants and water, with the water content ranging between bout 40% and 95% by weight based upon the weight of the entire composition, a unique, improved, liquid based foaming soap formulation is realized which is useable for a wide variety of applications, including wet

By providing a mixture of surfactants and water, with the water content ranging between bout 40% and 95% by weight based upon the weight of the entire composition, a unique, improved, liquid based foaming soap formulation is realized which is useable for a wide variety of applications, including wet shaving and dry shaving. In the preferred embodiment, the improved liquid based foaming soap formulations incorporate one or more therapeutic active in sufficient quantities to assure its efficacy. As a result, the formulation is useable for a wide variety of medical applications for preventing, treating, or reducing the spread or transmission of bacteria, virus, infections, and the like.

대표청구항 ▼

1. A delivery system for enabling the dispensing of a medicinal composition directly to an internal site in a human body, said medicinal composition comprises a therapeutic and anti-viral douche formulation, said delivery system comprising:A. a containera. constructed for receiving and retaining the

1. A delivery system for enabling the dispensing of a medicinal composition directly to an internal site in a human body, said medicinal composition comprises a therapeutic and anti-viral douche formulation, said delivery system comprising:A. a containera. constructed for receiving and retaining the medicinal compositions therein,b. incorporating an exit portal; andc. comprising a thin-walled, flexible construction;B. closure means mounted to the portal of the container for securely retaining the medicinal composition; and comprising a cap member affixed to the portal of the container for enabling the medicinal composition in said container to be dispensed directly to the desired internal site in the human body by inserting the elongated tube portion into an orifice of the human body, advancing the tube portion into the cavity associated therewith and enabling the medicinal composition to be dispensed directly to the desired site as pressure is applied to the thin walled, flexible container;C. a medicinal composition in the form of a therapeutic and anti-viral douche formulation comprising:a. between about 0.01% and 0.08% by weight based upon the weight of the entire composition of citric acid powder;b. between about 1% and 5% by weight based upon the weight of the entire composition of one selected from the group consisting of nonoxynol-9 and octoxynol-9;c. between about 8% and 12% by weight based upon the weight of the entire composition of glycerine;d. between about 0.30% and 2.0% by weight based upon the weight of the entire composition of povidone iodine;e. an effective amount of at least one therapeutic agent selected from the group consisting of silver nitrate solutions, silver nanocrystals, and equivalent compounds; andf. deionized water forming the balance;D. a delivery nozzle or cannula mounted to the closure means and comprising:a. an elongated tube portion having an overall length constructed for ease of insertion into an orifice communicating with a cavity of the human body, said overall length being constructed to assure the complete insertion of the tube portion into the cavity without injuring any surrounding tissue; andb. at least one aperture formed along the distal end of said elongated tube portion for enabling the douche formulation to be dispensed from the container through the tube portion directly to the desired site; andc. an elongated delivery channel formed by the internal diameter of said tube portion and constructed for controlling the delivery pressure produced by squeezing the thin-walled flexible container. 2. The delivery system defined in claim 1, wherein said delivery nozzle or cannula further comprises an enlarged surface formed adjacent the proximal end thereof, for providing a positive stop for said tube member in order to prevent over-insertion of said tube member into the cavity. 3. The delivery system and defined in claim 2, wherein said elongated tube portion is further defined as being formed from flexible material in order to assure ease of use and insertion thereof into the human body for being positioned in the precisely desired location. 4. The delivery system defined in claim 2, wherein said closure means is further defined as comprising one selected from the group consisting of caps and finger-operated dispensing valves, and the delivery nozzle/cannula is further defined as being securely affixed to said closure means in a manner which prevents dislodgement thereof from said closure means. 5. The delivery system defined in claim 4, wherein the elongated tube portion of the delivery nozzle/cannula is further defined as comprising a tapered outer surface with a smaller diameter section being formed at the distal end thereof for further assisting in providing ease of insertion and positioning of the tube member in the desired orifice. 6. The delivery system defined in claim 4, wherein the elongated tube portion of the delivery nozzle/cannula is further defined as comprising a subs tantially uniform diameter throughout the entire length thereof, with the distal end of said tube portion being smoothly rounded to assure ease of insertion into the desired orifice without injuring any surrounding tissue. 7. The delivery system defined in claim 1, wherein said douche formulation is further defined as comprising:A. 0.05% by weight based upon the weight of the entire composition of citric acid powder;B. 1.00% by weight based upon the weight of the entire composition of one selected from the group consisting of nonoxynol-9 and octoxylnol-9;C. 10% by weight based upon the weight of the entire composition of glycerine;D. 0.03% by weight based on the weight of the entire composition of povidone iodine;E. a suitable quantity of a fragrance, as needed; andF. deionized water forming the balance. 8. A delivery system for enabling the dispensing of medicinal compositions directly to an internal site in a human body, said delivery system comprising:A. a container constructed for receiving and retaining the medicinal compositions therein and incorporating an exit portal;B. closure means mounted to the portal of the container for securely retaining the medicinal composition; andC. a delivery nozzle or cannula mounted to the closure means and comprising:a. an elongated tube portion having an overall length constructed for ease of insertion into an orifice communicating with a cavity of the human body, said overall length being constructed to assure the complete insertion of the tube portion into the cavity without injuring any surrounding tissue; andb. at least one aperture formed along the distal end of said elongated tube portion for enabling the medicinal composition to be dispensed from the container through the tube portion directly to the desired site; andD. a check valve mounted in the container for preventing backflow into the container and comprising a cup member mounted in the portal of the container and said cup member comprises:a. a cylindrical shape closed at one end thereof;b. an aperture formed in the closed end;c. a ball member movably mounted in association with the aperture; andd. a disk incorporating a plurality of apertures formed therein, said disk being axially movable in said cup member through a limited distance for controlling the movement of the ball member into and out of the aperture. 9. The delivery system defined in claim 8, wherein said cup member further comprises an inwardly extending lip formed on an inside surface thereof adjacent the disk for controlling the axial movement of the disk. 10. A delivery system for enabling the dispensing of medicinal compositions directly to an internal site in a human body, said delivery system comprising:A. a containera. constructed for receiving and retaining the medicinal compositions therein,b. incorporating an exit portal; andc. a thin-walled, flexible construction;B. closure means mounted to the portal of the container for securely retaining the medicinal composition; and comprising a cap member affixed to the portal of the container for enabling the medicinal composition in said container to be dispensed directly to the desired internal site in the human body by inserting the elongated tube portion into an orifice of the human body, advancing the tube portion into the cavity associated therewith and enabling the medicinal composition to be dispensed directly to the desired site as pressure is applied to the thin walled, flexible container;C. a delivery nozzle or cannula mounted to the closure means and comprising:a. an elongated tube portion,1. having an overall length constructed for ease of insertion into an orifice communicating with a cavity of the human body, said overall length being constructed to assure the complete insertion of the tube portion into the cavity without injuring any surrounding tissue; and2. an elongated delivery channel formed by the internal diameter which is constructed for controlling the delivery pressure produced by sque ezing the flexible container, said internal diameter of said elongated tube portion being further defined as ranging between about 0.05 inches and 0.20 inches; andb. at least one aperture formed along the distal end of said elongated tube portion for enabling the medicinal composition to be dispensed from the container through the tube portion directly to the desired site. 11. The delivery system defined in claim 10, wherein said elongated tube portion is further defined as comprising an overall length ranging between about 2 inches and 3.5 inches. 12. The delivery system defined in claim 11, wherein the outer diameter of said elongated tube portion is further defined as ranging between about 0.25 inches and 0.35 inches. 13. The delivery system defined in claim 10, wherein the internal diameter of said elongated tube portion is further defined as ranging between about 0.08 inches and 0.156 inches.